Literature DB >> 32601456

Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement.

Nora Pashayan1, Antonis C Antoniou2, Urska Ivanus3, Laura J Esserman4, Douglas F Easton2, David French5, Gaby Sroczynski6,7, Per Hall8,9, Jack Cuzick10, D Gareth Evans11, Jacques Simard12, Montserrat Garcia-Closas13, Rita Schmutzler14, Odette Wegwarth15, Paul Pharoah2,16, Sowmiya Moorthie17, Sandrine De Montgolfier18, Camille Baron19, Zdenko Herceg20, Clare Turnbull21, Corinne Balleyguier22, Paolo Giorgi Rossi23, Jelle Wesseling24, David Ritchie25, Marc Tischkowitz26, Mireille Broeders27, Dan Reisel28, Andres Metspalu29, Thomas Callender1, Harry de Koning30, Peter Devilee31, Suzette Delaloge32, Marjanka K Schmidt24, Martin Widschwendter33,34,35.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2020        PMID： 32601456      PMCID： PMC7962565          DOI： 10.1038/s41571-020-0412-0

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   65.011


  4 in total

Review 1.  Molecular perspective on targeted therapy in breast cancer: a review of current status.

Authors:  Busra Demir Cetinkaya; Cigir Biray Avci
Journal:  Med Oncol       Date:  2022-07-14       Impact factor: 3.738

2.  Polygenic risk scores for prediction of breast cancer risk in Asian populations.

Authors:  Weang-Kee Ho; Mei-Chee Tai; Joe Dennis; Xiang Shu; Jingmei Li; Peh Joo Ho; Iona Y Millwood; Kuang Lin; Yon-Ho Jee; Su-Hyun Lee; Nasim Mavaddat; Manjeet K Bolla; Qin Wang; Kyriaki Michailidou; Jirong Long; Eldarina Azfar Wijaya; Tiara Hassan; Kartini Rahmat; Veronique Kiak Mien Tan; Benita Kiat Tee Tan; Su Ming Tan; Ern Yu Tan; Swee Ho Lim; Yu-Tang Gao; Ying Zheng; Daehee Kang; Ji-Yeob Choi; Wonshik Han; Han-Byoel Lee; Michiki Kubo; Yukinori Okada; Shinichi Namba; Sue K Park; Sung-Won Kim; Chen-Yang Shen; Pei-Ei Wu; Boyoung Park; Kenneth R Muir; Artitaya Lophatananon; Anna H Wu; Chiu-Chen Tseng; Keitaro Matsuo; Hidemi Ito; Ava Kwong; Tsun L Chan; Esther M John; Allison W Kurian; Motoki Iwasaki; Taiki Yamaji; Sun-Seog Kweon; Kristan J Aronson; Rachel A Murphy; Woon-Puay Koh; Chiea-Chuen Khor; Jian-Min Yuan; Rajkumar Dorajoo; Robin G Walters; Zhengming Chen; Liming Li; Jun Lv; Keum-Ji Jung; Peter Kraft; Paul D B Pharoah; Alison M Dunning; Jacques Simard; Xiao-Ou Shu; Cheng-Har Yip; Nur Aishah Mohd Taib; Antonis C Antoniou; Wei Zheng; Mikael Hartman; Douglas F Easton; Soo-Hwang Teo
Journal:  Genet Med       Date:  2021-12-15       Impact factor: 8.864

3.  Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening.

Authors:  Victoria G Woof; Lorna McWilliams; Louise S Donnelly; Anthony Howell; D Gareth Evans; Anthony J Maxwell; David P French
Journal:  Womens Health (Lond)       Date:  2021 Jan-Dec

4.  The local anesthetic ropivacaine suppresses progression of breast cancer by regulating miR-27b-3p/YAP axis.

Authors:  Lu Zhao; Shuang Han; Junde Hou; Wenhui Shi; Yonglei Zhao; Yongxue Chen
Journal:  Aging (Albany NY)       Date:  2021-06-14       Impact factor: 5.682
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.